Related references
Note: Only part of the references are listed.Phosphoramidates of 2′-β-D-arabinouridine (AraU) as phosphate prodrugs; design, synthesis, in vitro activity and metabolism
Youcef Mehellou et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
Cationic lipid-mediated nucleic acid delivery: beyond being cationic
N. Madhusudhana Rao
CHEMISTRY AND PHYSICS OF LIPIDS (2010)
Biodegradable polymeric nanoparticles based drug delivery systems
Avnesh Kumari et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2010)
Induction therapy in acute myeloid leukemia: intensifying and targeting the approach
Hugo F. Fernandez et al.
CURRENT OPINION IN HEMATOLOGY (2010)
Strategy for effective brain drug delivery
M. Intakhab Alam et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2010)
Liposomal cancer therapy: exploiting tumor characteristics
Thomas Kaasgaard et al.
EXPERT OPINION ON DRUG DELIVERY (2010)
Emerging drugs for chronic myeloid leukemia
Daniela Cilloni et al.
EXPERT OPINION ON EMERGING DRUGS (2010)
Emerging therapy for the treatment of acute lymphoblastic leukemia
Amber Fullmer et al.
EXPERT OPINION ON EMERGING DRUGS (2010)
Pharmacogenomics of pediatric acute lymphoblastic leukemia
Nathan D. Meeker et al.
EXPERT OPINION ON PHARMACOTHERAPY (2010)
Clinical applications of PET and PET/CT in pediatric malignancies
Rakesh Kumar et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2010)
Leukemia-selective uptake and cytotoxicity of CPX-351, a synergistic fixed-ratio cytarabine:daunorubicin formulation, in bone marrow xenografts
Wah-Seng Lim et al.
LEUKEMIA RESEARCH (2010)
The molecular pathology of cancer
Timothy J. R. Harris et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
Targeting Anticancer Drugs to Tumor Vasculature Using Cationic Liposomes
Amr S. Abu Lila et al.
PHARMACEUTICAL RESEARCH (2010)
Current issues in research on structure-property relationships in polymer nanocomposites
J. Jancar et al.
POLYMER (2010)
Novel Drug Delivery Systems for Sustained and Targeted Delivery of Anti-Cancer Drugs: Current Status and Future Prospects
Puneet Utreja et al.
Current Drug Delivery (2010)
Intravenous administration of CP-4055 (ELACYT (TM)) in patients with solid tumours. A phase I study
Svein Dueland et al.
ACTA ONCOLOGICA (2009)
Special feature of mixed phosphotriester derivatives of cytarabine
Marie-Helene Gouy et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2009)
CP-4055 and CP-4126 are active in ara-C and gemcitabine-resistant lymphoma cell lines
Carlos M. Galmarini et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Advances in gene delivery through molecular design of cationic lipids
Santanu Bhattacharya et al.
CHEMICAL COMMUNICATIONS (2009)
Current and Emerging Therapies for Acute Myeloid Leukemia
Tadeusz Robak et al.
CLINICAL THERAPEUTICS (2009)
Chitosan-Based Thermosensitive Hydrogel Containing Liposomes for Sustained Delivery of Cytarabine
Rohit Mulik et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2009)
Synthesis and evaluation of anti-tumor activities of N4 fatty acyl amino acid derivatives of 1-β-arabinofuranosylcytosine
Boyang Liu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2009)
Prodrug approaches to improving the oral absorption of antiviral nucleotide analogues
Larryn W. Peterson et al.
EXPERT OPINION ON DRUG DELIVERY (2009)
Ligand-based targeted therapy for cancer tissue
Manasi Das et al.
EXPERT OPINION ON DRUG DELIVERY (2009)
Emerging trends of nanomedicine - an overview
Selvarajan Sandhiya et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2009)
Niosomes in sustained and targeted drug delivery: some recent advances
Adnan Azeem et al.
JOURNAL OF DRUG TARGETING (2009)
Pharmacokinetics of CPX-351 (Cytarabine/Daunorubicin HCl) Liposome Injection in the Mouse
William F. Bayne et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2009)
Synthesis, Transport and Pharmacokinetics of 5 '-Amino Acid Ester Prodrugs of 1-beta-D-Arabinofuranosylcytosine
Yongbing Sun et al.
MOLECULAR PHARMACEUTICS (2009)
A novel regimen combining high dose cytarabine and bortezomib has activity in multiply relapsed and refractory mantle cell lymphoma - long-term results of a multicenter observation study
Oliver Weigert et al.
LEUKEMIA & LYMPHOMA (2009)
In vivo maintenance of synergistic cytarabine:daunorubicin ratios greatly enhances therapeutic efficacy
Paul Tardi et al.
LEUKEMIA RESEARCH (2009)
Comparison of ICE (ifosfamide-carboplatin-etoposide) versus DHAP (cytosine arabinoside-cisplatin-dexamethasone) as salvage chemotherapy in patients with relapsed or refractory lymphoma
Hueseyin Abali et al.
CANCER INVESTIGATION (2008)
Liposomal cytarabine for leukemic and lymphomatous meningitis: recent developments
Martin Benesch et al.
EXPERT OPINION ON PHARMACOTHERAPY (2008)
Recent advances in management of acute myeloid leukemia (AML)
Manasi Shah et al.
INDIAN JOURNAL OF PEDIATRICS (2008)
Prodrugs of nucleoside analogues for improved oral absorption and tissue targeting
Fujun Li et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2008)
Anti proliferative activity of ELACYT™ (CP-4055) in combination with cloretazine (VNP40101M), idarubicin, gemcitabine, irinotecan and topotecan in human leukemia and lymphoma cells
David J. Adams et al.
LEUKEMIA & LYMPHOMA (2008)
Modern Approaches to Treating Chronic Myelogenous Leukemia
Javier Pinilla-Ibarz et al.
CURRENT ONCOLOGY REPORTS (2008)
Current and emerging treatment options in chronic myeloid leukemia
Elias Jabbour et al.
CANCER (2007)
Nanoparticular drug delivery system of cytarabine hydrochloride (CTH) for improved treatment of lymphoma
K. Ruckmani et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2007)
Nucleoside analogue delivery systems in cancer therapy
Roudayna Diab et al.
EXPERT OPINION ON DRUG DELIVERY (2007)
A pharmacokinetic study of intra-CSF administered encapsulated cytarabine (DepoCyt (R)) for the treatment of neoplastic meningitis in patients with leukemia, lymphoma, or solid tumors as part of a phase III study
Surasak Phuphanich et al.
JOURNAL OF NEURO-ONCOLOGY (2007)
Synthesis and biological evaluation of a cytarabine phosphoramidate prodrug
Sandra C. Tobias et al.
MOLECULAR PHARMACEUTICS (2004)
Antiproliferative activity and mechanism of action of fatty acid derivatives of arabinofuranosylcytosine in leukemia and solid tumor cell lines
AM Bergman et al.
BIOCHEMICAL PHARMACOLOGY (2004)
Carboxylic acid and phosphate ester derivatives of fluconazole: synthesis and antifungal activities
NH Nam et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2004)
Antiproliferative activity and mechanism of action of fatty acid derivatives of arabinosylcytosine (ara-C) in leukemia and solid tumor cell lines
AM Bergman et al.
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2004)
An open label trial of sustained-release cytarabine (DepoCyt™) for the intrathecal treatment of solid tumor neoplastic meningitis
KA Jaeckle et al.
JOURNAL OF NEURO-ONCOLOGY (2002)
Chitosan microspheres in PLG films as devices for cytarabine release
MD Blanco et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2000)
Results of treatment with Hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia
HM Kantarjian et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
H Maeda et al.
JOURNAL OF CONTROLLED RELEASE (2000)
Share Paper
